Parent Preferences for Health Outcomes Associated with Autism Spectrum Disorders

Tara A. Lavelle (), Milton C. Weinstein, Joseph Newhouse, Kerim Munir, Karen A. Kuhlthau and Lisa A. Prosser
Additional contact information
Tara A. Lavelle: Tufts Medical Center
Milton C. Weinstein: Harvard T.H. Chan School of Public Health
Kerim Munir: Boston Children’s Hospital
Karen A. Kuhlthau: Harvard Medical School
Lisa A. Prosser: University of Michigan

PharmacoEconomics, 2019, vol. 37, issue 4, No 9, 551 pages

Abstract: Abstract Background Few studies have used preference-based quality-of-life outcomes to assess how autism spectrum disorders (ASDs) affect children and parents, and none have examined variation by ASD severity. Objective Our objective was to derive parent valuations of child and parent health associated with varying ASD severity levels. Methods Parents of children aged 3–17 years with and without ASD were selected from a nationally representative research panel to complete a survey. We asked parents time trade-off (TTO) questions to value their own and their child’s current health. Parents of children with ASD were asked to report the severity of their child’s core ASD symptoms. We calculated utility values from each TTO amount, and used a two-part regression model to estimate the change in parent-reported child health utility, as well as parent health utility, associated with ASD diagnosis and increasing symptom severity, controlling for respondent and child characteristics. Results Sixty-nine percent of parents responded (final sample size was 135 in the ASD group and 120 in the comparison group). In adjusted analyses, there was a 0.12 (95% confidence interval [CI] 0.03–0.21) decrease in the parent-reported health utility of children with ASD, a 15% decrease from the mean health utility of children without ASD. On average, having a child with ASD was not significantly associated with a decrease in parent health utility, but there was a 0.14 (95% CI 0.01–0.26) reduction in health utility among parents of children with severe ASD, a 15% decrease from the comparison group mean. Conclusions Overall, ASD had a significant impact on parent-reported child health utility, and the health utility of parents of children with severe ASD.

Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://link.springer.com/10.1007/s40273-019-00783-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00783-8

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-019-00783-8

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().